Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function

International Immunopharmacology(2023)10.1016/j.intimp.2023.111145Source: DataRank Database

The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function is a research paper published in International Immunopharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

8 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.73)OA: closedTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Yuichi Yokoyama ORCID,Taku Yoshida ORCID,Yohei Okada ORCID,Masaomi Takizawa,Osamu Ikeda ORCID

Live enrichment

PubMed:37935092 OpenAlex:https://openalex.org/W4388396179

National Institutes of Health

Grant: R01HL111501

Astellas Pharma Inc

Astellas Pharma US

FWCI

0.73

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S1567576923014716?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1567576923014716?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.intimp.2023.111145

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37935092

Fields of Study

Immune Cell Function and InteractionT-cell and B-cell ImmunologyCAR-T cell therapy researchHumansDiacylglycerol KinaseKiller Cells, NaturalNeoplasmsSignal TransductionT-LymphocytesOrganic Chemicals

MeSH Terms

HumansKiller Cells, NaturalNeoplasmsOrganic ChemicalsT-LymphocytesSignal TransductionDiacylglycerol Kinase

Keywords

Diacylglycerol kinaseCell biologyCancer immunotherapyT cellBiologyReceptorSignal transductionImmunotherapyCancer researchImmune systemImmunologyProtein kinase CBiochemistryNK cellsERKDagDgkζDgk Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being

The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function

FAIR Checklist

Authors (7)

Funding (3 grants)

Impact

Open Access

Topics